Caption Management’s Edwards Lifesciences EW Stock Holding History

Caption Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-55,000	Closed	-$4.07M	–	1673
2024 Q4	$4.07M	Buy	+55,000	New	+$3.85M	0.04%	434
2023 Q4	–	Sell	-60,000	Closed	-$4.16M	–	1430
2023 Q3	$4.16M	Buy	+60,000	New	+$4.82M	0.06%	366
2023 Q1	–	Sell	-100,000	Closed	-$7.46M	–	1227
2022 Q4	$7.46M	Buy	+100,000	New	+$7.71M	0.12%	216
2022 Q1	–	Sell	-10,000	Closed	-$1.3M	–	1604
2021 Q4	$1.3M	Sell	10,000 -20,000	-67%	-$2.33M	0.01%	951
2021 Q3	$3.4M	Buy	30,000 +20,000	+200%	+$2.28M	0.04%	585
2021 Q2	$1.03M	Buy	+10,000	New	+$943K	0.01%	882
2019 Q2	–	Sell	-197,100	Closed	-$12.6M	–	708
2019 Q1	$12.6M	Buy	+197,100	New	+$11.2M	0.69%	24

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Caption Management's EW Position: Q3 2025 in Review

Caption Management sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 7,012 shares — an estimated $548K sold.

Caption Management first reported a position in EW in Q4 2017 and held it in 8 quarters. The position peaked at $8.14M in Q3 2021. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Caption Management reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
Caption Management sold 7,012 Edwards Lifesciences shares in Q3 2025, an estimated $548K.
Caption Management first reported a position in Edwards Lifesciences in Q4 2017 and held it in 8 quarters.
Caption Management's Edwards Lifesciences position peaked at $8.14M in Q3 2021.
1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.